ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS
(Before April 2001)

from April 2001:


  Maintenance interferon for chronic hepatitis C: More issues than answers?
     
Written by Gregory T. Everson, M.D.
(with full PDF of this article)
(4/30/2001)

  Index of 5 Blood Tests Used to Predict Liver Fibrosis Instead of Biopsy
     Article written by French Hepatitis research group

(4/30/2001)

  Avascular Necrosis in HIV: case studies
With full report of this study in PDF format
(4/12/2001)

  Virologic Response To Pegasys With Genotype 4 in Small Study Group
(4/10/2001)

   Excerpts from Press Announcement Of Application to the FDA for 1 Efavirenz Pill Per Day Instead of 3 200 mg Pills
(4/10/2001)

   Study Finds Increasing HIV Incidence Among Women: almost 300% from 1986 to 1999
(4/5/2001)

   It's Time to Research TDM
The Time Has Come To Accelerate Research Into Using TDM To Adjust Low Drug Blood Levels For the Purpose Of Improving Viral Load Response to HAART
(4/5/2001)

  Merck Experimental Therapeutic HIV Vaccine
Articles from Reuters & the Wall St. Journal
(4/3/2001)

  Highlights from
The 36th Annual Meeting of EASL
(European Association for the Study of the Liver) April 18-22, 2001, Prague, Czech Republic

    
Written for NATAP by Harvey S. Bartnof, MD
(4/21/2001)

  Report for NATAP from the
4th International Conference on Nutrition and HIV Infection
Second European Workshop on Lipodystrophy
    
Written for NATAP by Graeme Moyle, MD, MBBS
(4/27/2001)

   Reports for NATAP from the
2nd International Workshop on Clinical Pharmacology of HIV Therapy
April 2-4, 2001 Noordwijk, the Netherlands
(4/10/2001)

  Maintenance interferon for chronic hepatitis C: More issues than answers?
     
Written by Gregory T. Everson, M.D.
(with full PDF of this article)
(4/30/2001)

  Index of 5 Blood Tests Used to Predict Liver Fibrosis Instead of Biopsy
     Article written by French Hepatitis research group

(4/30/2001)

  Avascular Necrosis in HIV: case studies
With full report of this study in PDF format
(4/12/2001)

  Virologic Response To Pegasys With Genotype 4 in Small Study Group
(4/10/2001)

   Excerpts from
Press Announcement Of Application to the FDA for 1 Efavirenz Pill Per Day Instead of 3 200 mg Pills
(4/10/2001)

   Study Finds Increasing HIV Incidence Among Women: almost 300% from 1986 to 1999
(4/5/2001)

   It's Time to Research TDM
The Time Has Come To Accelerate Research Into Using TDM To Adjust Low Drug Blood Levels For the Purpose Of Improving Viral Load Response to HAART
(4/5/2001)

  Merck Experimental Therapeutic HIV Vaccine
Articles from Reuters & the Wall St. Journal
(4/3/2001)

OLDER REPORTS AND DEVELOPMENTS FROM: